EDGAR Filing Documents for 0001171843-20-004618

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001171843-20-004618

Filing Date

2020-06-29

Accepted

2020-06-29 18:18:14

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3	s3_062920.htm	S-3	518932
2	EXHIBIT 1.2	exh_12.htm	EX-1.2	241777
3	EXHIBIT 5.1	exh_51.htm	EX-5.1	28057
4	EXHIBIT 23.1	exh_231.htm	EX-23.1	5452
5	EXHIBIT 23.3	exh_233.htm	EX-23.3	5781
6	EXHIBIT 23.4	exh_234.htm	EX-23.4	4709
7	GRAPHIC	kpmg.jpg	GRAPHIC	3322
8	GRAPHIC	logo.jpg	GRAPHIC	5759
9	GRAPHIC	oslerlogo.jpg	GRAPHIC	9713
	Complete submission text file	0001171843-20-004618.txt		826551

Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3

Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)